Browsing Resources in English by Subject "Angiotensin-Converting Enzyme Inhibitors"
Now showing items 1-5 of 5
-
ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study
(2020-05-01)Aims: The question of interactions between the renin angiotensin aldosterone system drugs and the incidence and prognosis of COVID-19 infection has been raised by the medical community. We hypothesised that if patients ... -
Angiotensin‐converting enzyme‐2 (ACE2 ), SARS‐CoV ‐2 and pathophysiology of coronavirus disease 2019 (COVID ‐19)
(2020-05-17)[Abstract]. Angiotensin‐converting enzyme‐2 (ACE2) has been established as the functional host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus responsible for the current devastating ... -
Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol
(2020-07-14)Background: The SARS-CoV-2 virus causing COVID-19 binds human angiotensin-converting enzyme 2 (ACE2) receptors in human tissues. ACE2 expression may be associated with COVID-19 infection and mortality rates. Routinely ... -
Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19
(2020-03-27)This article reviews the correlation between angiotensin‐converting enzyme 2 (ACE2) and severe risk factors for coronavirus disease 2019 (COVID‐19) and the possible mechanisms. ACE2 is a crucial component of the renin‐angiotensin ... -
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
(2020-07-01)Objective It has been hypothesised that the use of ACE inhibitors and angiotensin receptor blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The findings from the available observational ...